Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19333 W North Ave
Brookfield, WI 53045Phone+1 262-780-4111
Education & Training
- Main Line Health System/Lankenau Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- Temple University HospitalResidency, Internal Medicine, 2012 - 2015
- Howard University College of MedicineClass of 2012
Certifications & Licensure
- WI State Medical License 2018 - 2025
- PA State Medical License 2012 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsBrief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis.Monika A Izano, Connor Sweetnam, Chenan Zhang, James L Weese, Douglas Reding
Clinical Lung Cancer. 2023-06-01 - 20 citationsRadiation therapy in the last month of life.Anand Patel, Jacquelyn Dunmore-Griffith, Stephen Lutz, Peter A. S. Johnstone
Reports of Practical Oncology and Radiotherapy. 2014-05-01
Journal Articles
- Dramatic Response to Olaparib in a Patient With Metastatic Castration- Resistant Prostate CancerAnand D. Patel, MD; Jessica Katz, MD, PhD, FACP; Terri W. McHugh, DO; Rachael T. Brandt, PhD, MS ; Cristina Nixon, MS; Paul B. Gilman, MD; and John Sobuto, DO, The Journal of Targeted Therapies in Cancer, 5/2/2018
- Radiation therapy in the last month of lifeAnand Patel, Jacquelyn Dunmore-Griffith, Stephen Lutz, Peter A.S. Johnstone, Reports of Practical Oncology and Radiotherapy, 10/16/2013
Press Mentions
- Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence PreventionMay 12th, 2022
- Research Reveals a Therapeutic Opportunity to Prevent Rhabdomyosarcoma RecurrenceApril 27th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: